- Home
- ASLE vs CERS Comparison
ASLE vs CERS Comparison
Compare ASLE & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASLE | CERS |
|---|---|---|
| Founded | 2008 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 336.9M | 276.0M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ASLE | CERS |
|---|---|---|
| Price | $6.44 | $1.78 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 203.5K | ★ 1.6M |
| Earning Date | 06-08-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.64 | 27.27 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $335,286,000.00 | $51,326,000.00 |
| Revenue This Year | $24.23 | $20.00 |
| Revenue Next Year | $23.67 | $9.60 |
| P/E Ratio | $108.08 | ★ N/A |
| Revenue Growth | N/A | ★ 30.68 |
| 52 Week Low | $5.56 | $1.12 |
| 52 Week High | $9.08 | $2.96 |
Technical Indicators
Market Signals| Indicator | ASLE | CERS |
|---|---|---|
| Relative Strength Index (RSI) | 27.20 | 32.87 |
| Support Level | $5.71 | $1.34 |
| Resistance Level | $6.56 | $2.26 |
| Average True Range (ATR) | 0.25 | 0.18 |
| MACD | -0.14 | -0.07 |
| Stochastic Oscillator | 18.52 | 2.22 |
Price Performance
Historical ComparisonAbout ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.